Literature DB >> 29799915

Timolol Eyedrops in the Treatment of Acute Migraine Attacks: A Randomized Crossover Study.

Matthew Cossack1, Edward Nabrinsky1, Heath Turner1, Ashley Abraham1, Sean Gratton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29799915      PMCID： PMC6142935          DOI： 10.1001/jamaneurol.2018.0970

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  4 in total

1.  Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.

Authors:  Juha-Matti Korte; Timo Kaila; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-04-26       Impact factor: 3.117

2.  Topical beta-blocker treatment for migraine.

Authors:  Patrick J T Chiam
Journal:  Int Ophthalmol       Date:  2012-01-26       Impact factor: 2.031

Review 3.  Beta blocker eye drops for treatment of acute migraine.

Authors:  Carl V Migliazzo; John C Hagan
Journal:  Mo Med       Date:  2014 Jul-Aug

4.  Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.

Authors:  A Urtti; H Rouhiainen; T Kaila; V Saano
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200
  4 in total
  6 in total

Review 1.  Approach to Pediatric Intractable Migraine.

Authors:  Mohammed Alqahtani; Rebecca Barmherzig; Ana Marissa Lagman-Bartolome
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-04       Impact factor: 5.081

2.  Errors in the Table and Results.

Authors: 
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

3.  Error in Data Presentation in Text.

Authors: 
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

4.  Migraine relief in 20 minutes using eyedrops?

Authors:  Yufei Ge; Gregory Castelli
Journal:  J Fam Pract       Date:  2022-06       Impact factor: 0.725

5.  It Should Not Be This Difficult to Engage Pharma in an Effective, Safe, Inexpensive Product for Acute Migraine, the Third Most Prevalent Disease in the World.

Authors:  John C Hagan
Journal:  Mo Med       Date:  2022 Jan-Feb

6.  A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.

Authors:  Dipika Aggarwal; Andrew J Heim; Brennen Bittel; Deetra Ford; Richard Dubinsky; Gary Gronseth; Vernita Hairston; Patrick Landazuri; Fred Sachen; Laura Herbelin; Richard J Barohn
Journal:  Kans J Med       Date:  2020-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.